Tel: +44 (0)20 7377 0800
Fax: +44 (0)20 7349 5157
Tel: +81 (0)80-1164-4754
Request a Demo
What our customers are saying
When I think of the future, I think of EvaluatePharma
Global pharmaceutical company
Anthony Raeside, Head of Research.
|Mr. Raeside leads Evaluate's analyst teams, currently numbering over 95 staff globally, providing life science sector analysis and commercial insight into the biotechnology, pharmaceutical and medical device industries. He also is responsible for research strategy and development to continually enhance the value of Evaluate services to its client base. He is a graduate of the London School of Economics and Political Science.
Ian Strickland, Commercial Product Manager, EvaluateMedTech™
||Mr. Strickland started with Evaluate in 2000 after graduating from the University of Nottingham in the UK. After serving as an Analyst he held the role of Product Manager of EvaluatePharma from 2007-2008. He also worked for Propagate Pharma as Senior Business Analyst before returning to Evaluate in 2010. Since his return he has focused on data and analytical development and implementation of EvaluateClinical Trials and EvaluateMedTech, a new premier service focused on the medical device and diagnostics industry, and was recently appointed as Commercial Product Manager of the latter product.|
Jonathan Moser, Senior Analyst, EvaluatePharma®
|Mr. Moser has over eight years in-house experience at Evaluate specializing in forecast, financial and epidemiological data. He takes an active role in product development and was instrumental in the development and introduction of EvaluatePharma’s Sales by Indication, Epidemiology data and Indication Overviews. He is a graduate of Warwick University.
EP Vantage Team
EP Vantage’s award-winning editorial team consists of:
Lisa Urquhart, Editor
|A journalist with more than a decade of experience, Lisa joined Evaluate's EP Vantage editorial team after a solid career at the Financial Times in London, including time as biotechnology correspondent. She generated a number of exclusive reports during her seven years at the Financial Times. An active contributor to industry panels, Lisa has also commented on the pharmaceutical industry on both television and radio.
Amy Brown, Senior Reporter
||Amy joined EP Vantage from Thomson Financial News, where she covered the European pharmaceutical and biotechnology sectors for several years. She has extensive experience working as a financial journalist, working for companies including Bloomberg News, and has been a contributor to publications such as Corporate Financier and the Sunday Times.|
Jonathan Gardner, Reporter
|Mr. Gardner extends the editorial reach of EP Vantage with his wealth of knowledge on the U.S. primary healthcare market and regulatory affairs issues. He joined EP Vantage after having worked as freelance journalist for a number of respected healthcare publications, including Elsevier Global Medical News. Mr. Gardner also has served as communications manager for Health Affairs Journal and as bureau chief for Modern Healthcare, a magazine covering medical business news and research.
Jacob Plieth, Senior Editorial Analyst
||Jacob has 16 years’ experience of writing about healthcare and joined EP Vantage in 2012 from Edison Investment Research, where he had spent five years as an equity research analyst covering European biotech. He has also worked at Dow Jones and the Wall Street Journal, where he co-wrote a column focused on the pharmaceutical industry, and spent seven years as a reporter and editor at Scrip Pharmaceutical News. He is a biochemist by training, and has spoken about pharmaceutical and other topics on the BBC World Service and News 24, as well as contributing to publications including Investors Chronicle and Mednous. Before joining Scrip, Jacob worked as a senior editor at Pharmaprojects. |
Elizabeth Cairns, Reporter
Most recently a journalist at Informa where she wrote for Clinica Medtech Intelligence and Scrip, Elizabeth has ten years’ experience monitoring the medtech, biotech and pharmaceutical sectors. With her solid science background, she is able to interpret complex data and communicate their business implications. In the course of her career she has observed a minimally invasive prostatectomy using robotic surgery equipment at Kings College Hospital and visited one of Boston Scientific’s factories to see the process by which coronary stents are produced.
Joanne Fagg, Editorial Assistant
||Joanne has an MSc in Molecular Medicine from Imperial College London and has previous experience working in Research & Development for a biopharmaceutical company. She has also worked in healthcare publishing and communications. Responsible for the smooth running of EP Vantage’s social media efforts and electronic publications, Joanne is increasing her understanding of the pharmaceutical industry by working and supporting members of the EP Vantage team. |